b'Media Pitch Day in ActionWATCH VIDEO GelSana RefinedScienceMaking a Material Impact onIdentifying Novel Cellular Advancing Wound Care TargetsGelSana is bringing an entirely newRefinedScience is a precision medicine class of materials to the wound carecompany devoted to identifying novel field to improve patient outcomes andcellular targets as well as promising quality of life. GelSana engineers highly elastic wound dressingand safe new agents against treatment resistant cancers and hydrogels which can stretch and conform across any wound,other diseases. It mines big data sets curated with accurate and reduce inflammation, prevent infection, and provide sustained drugdeep clinical annotation on patient features including outcomes delivery over time.and treatment toxicities. WATCH PITCH WATCH PITCHHepQuant STAQ PharmaPersonalizing Chronic LiverBolstering Supply Chain Disease Managementto Address Critical Drug HepQuant develops non-invasive,Shortages quantitative tests that measure liverSTAQ Pharma is a trusted 503B health. The HepQuant DuO Test is aOutsourcing Facility that makes Laboratory Developed Test (LDT) that enables healthcare providerscompounded medications for hospitals, surgery centers, and to manage patients with liver diseases more effectively. It deliversphysician-led practices. STAQ Pharma is widely known for its work information about liver cell function and portal-systemic shunting. in addressing critical drug shortages in the U.S. and producing Albuterol for childrens hospitals.WATCH PITCHWATCH PITCHOncoVerity Vona OncologyFighting Cancer with DataMarketing First-In-Class and Wisdom Small Molecule Drug for OncoVerity is pioneering the useAggressive Cancersof a proprietary precision medicineVona Oncology is developing targeted platform to better the lives of patientstherapeutics to treat aggressive battling cancer. OncoVeritys approach leverages the University ofcancers such as triple-negative breast cancer (TNBC), ovarian Colorado Anschutz Medical Campus and UCHealth infrastructurecancer, and melanoma. Vona Oncology has an innovative, novel in single-cell multi-omics analysis and machine learning alongsidesmall molecule that is very efficacious at low doses with little one of the most comprehensive and highly curated acute myeloidtoxicity observed in pre-clinical studies.leukemia (AML) clinical databases to develop therapeutic solutions for patients. WATCH PITCHWATCH PITCH15'